Wed, 29 Sep 2021

DelveInsight's Hepatitis D Virus Infection Market Insights Report offers a detailed analysis of the disease, its causes, symptoms, diagnostics modalities, and treatment options.

The Hepatitis D Virus Infection market report also offers comprehensive insights into Hepatitis D Virus Infection market size, epidemiology, emerging therapies, market drivers, market barriers, ongoing clinical trials, key collaboration in the space, and key pharmaceutical companies actively pushing the growth of Hepatitis D Virus Infection market size forward.

Hepatitis D Virus (HDV) Infection Market

Some of the key highlights from the Hepatitis D Virus Infection Market Insights:

  • According to the World Health Organization (WHO) estimates, the Hepatitis D virus (HDV) globally affects nearly 5% of people who have a chronic infection with hepatitis B virus (HBV).
  • In the 7MM, the total diagnosed HDV prevalent cases were found to be around 221,585 in 2018. These cases are expected to grow with a significant CAGR in the study period 2018–2030.
  • In EU-5 countries the highest number of diagnosed prevalent cases of HDV was in Germany followed by Italy, Spain, the United Kingdom, and France.
  • Major pharmaceutical players such as MYR Pharmaceuticals/Hepatera, Eiger Biopharmaceuticals, Janssen Pharmaceuticals, and others are involved in developing therapies for the treatment and management of Hepatitis D Virus Infection. These therapies are currently under different stages of development.
  • Key pipeline therapies in the Hepatitis D Virus Infection market include Hepcludex/Bulevirtide, Lonafarnib, JNJ-73763989, among others.

Learn more by requesting for sample @ Hepatitis D Virus Infection Market Landscape

Hepatitis D Virus Infection: Overview

Hepatitis D Virus Infection is a viral infection that causes liver inflammation, sometimes leading to serious liver damage. It is caused by the hepatitis D virus (HDV) and is considered to be the most severe form of viral hepatitis in humans due to more rapid progression toward liver-related death and hepatocellular carcinoma.

Hepatitis D Virus Infection requires hepatitis B virus (HBV) for its replication. HDV infection occurs as co-infection or as super-infection with HBV.

HDV affects nearly 5% of people who have a chronic infection with HBV and that HDV co-infection could explain about 1 in 5 cases of liver disease and liver cancer in people with HBV infection.

For more insights into Disease, causes, and treatment, reach out to Hepatitis D Virus Infection Treatment Landscape

Hepatitis D Virus Infection Epidemiology Segmentation

The Hepatitis D Virus Infection Market report proffers epidemiological analysis for the study period 2017-30 in the 7MM segmented into:

  • Hepatitis D Virus Infection Prevalence
  • Age-Specific Hepatitis D Virus Infection Prevalence
  • Gender-Specific Hepatitis D Virus Infection Prevalence
  • Diagnosed and Treatable Cases of Hepatitis D Virus Infection

Visit for more @ Hepatitis D Virus Infection Epidemiological Insights

Hepatitis D Virus Infection Market

The Hepatitis D Virus (HDV) market dynamics is anticipated to change in the coming years. Key players, such as MYR Pharmaceuticals, Eiger Biopharmaceuticals, and Janssen Pharmaceuticals, etc. are involved in developing drugs for Hepatitis D Virus (HDV).

Hepatitis D Virus Infection Pipeline Therapies and Key Companies

  • Hepcludex/Bulevirtide: MYR Pharmaceuticals/Hepatera
  • Lonafarnib: Eiger Biopharmaceuticals
  • JNJ-73763989: Janssen Pharmaceuticals

For more information, visit Hepatitis D Virus Infection Market Analysis, Patient Pool and Emerging Therapies

Hepatitis D Virus Infection Market Drivers

  • Rising prevalent population
  • Technological advancements
  • Emerging therapies
  • Extensive R&D

Scope of the Report

  • 11 Years Forecast
  • 7MM Coverage
  • Descriptive overview of Hepatitis D Virus Infection, covering causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight into Hepatitis D Virus Infection epidemiology and treatment in the 7MM
  • Current and emerging therapies for Hepatitis D Virus Infection
  • Hepatitis D Virus Infection market drivers and barriers

Key Questions Answered in the Report

  • What was the Hepatitis D Virus Infection market share (%) distribution in 2017 and how it would look like in 2030?
  • What would be the Hepatitis D Virus Infection total market size as well as market size by therapies across the 7MM during the forecast period (2017-2030)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Hepatitis D Virus Infection market size during the forecast period (2017-2030)?
  • At what CAGR, the Hepatitis D Virus Infection market is expected to grow in 7MM during the forecast period (2017-2030)?

Get in touch with our Business executive @ Hepatitis D Virus Infection Market Landscape Analysis

Table of Contents

1.

Key Insights

2.

Report Introduction

3.

Competitive Intelligence Analysis for Hepatitis D Virus Infection

4.

Hepatitis D Virus Infection Market Overview at a Glance

5.

Executive Summary of Hepatitis D Virus Infection

6.

Hepatitis D Virus Infection Epidemiology and Market Methodology

7.

Hepatitis D Virus Infection Epidemiology and Patient Population

8.

Hepatitis D Virus Infection Patient Journey

9.

Treatment Algorithm, Current Treatment, and Medical Practices

10.

Key Endpoints in Hepatitis D Virus Infection Clinical Trials

11.

Hepatitis D Virus Infection Marketed Therapies

12.

Hepatitis D Virus Infection Emerging Therapies

13.

Hepatitis D Virus Infection: 7 Major Market Analysis

14.

Attribute analysis

15.

Access and Reimbursement Overview of Hepatitis D Virus Infection

16.

KOL Reviews

17.

Case Reports

18.

Hepatitis D Virus Infection Market Drivers

19.

Hepatitis D Virus Infection Market Barriers

20.

SWOT Analysis

21.

Disclaimer

22.

DelveInsight Capabilities

23.

About DelveInsight

Learn more about the report offerings @ Hepatitis D Virus Infection Market Outlook

Related Reports:

Hepatitis D Virus Infection Epidemiology

DelveInsight's 'Hepatitis D Virus Infection - Epidemiology Forecast to 2030' report.

Hepatitis D Virus Infection Pipeline

DelveInsight's 'Hepatitis D Pipeline Insight' report.

Latest Reports:

Intrahepatic Cholangiocarcinoma (ICCA) Market

DelveInsight's 'Intrahepatic Cholangiocarcinoma (ICCA) - Market Insights, Epidemiology, and Market Forecast–2030' report.

COVID 19 Therapeutic Pipeline, Vaccines, and Diagnostics Competitive Landscape, 2020

DelveInsight's 'COVID 19 (Novel Coronavirus 19) Therapeutic Pipeline, Vaccines, and Diagnostics Competitive Landscape, 2020' report.

Cervical Dysplasia Market

DelveInsight's "Cervical Dysplasia - Market Insights, Epidemiology, and Market Forecast-2030" report.

Agoraphobia Market

DelveInsight's "Agoraphobia - Market Insights, Epidemiology, and Market Forecast-2030" report.

Hydrocephalus Market

DelveInsight's "Hydrocephalus - Market Insights, Epidemiology, and Market Forecast-2030" report.

Sarcopenia Market

DelveInsight's 'Sarcopenia–Market Insights, Epidemiology, and Market Forecast-2030' report.

Diabetic Kidney Disease Market

DelveInsight's "Diabetic Kidney Disease (DKD) - Market Insights, Epidemiology, and Market Forecast-2030" report.

Acromegaly Market

DelveInsight's 'Acromegaly-Market Insights, Epidemiology, and Market Forecast–2030' report.

Acute Respiratory Distress Syndrome (ARDS) Market

DelveInsight's 'Acute Respiratory Distress Syndrome (ARDS) - Market Insights, Epidemiology and Market Forecast - 2030' report.

Acute Kidney Injury (AKI) Market

DelveInsight's 'Acute Kidney Injury (AKI) - Market Insights, Epidemiology and Market Forecast– 2030' report.

Renal Anemia Market

DelveInsight's "Renal Anemia - Market Insights, Epidemiology, and Market Forecast-2030" report.

Healthcare Blogs:

Search for the Cure Continues in the Chronic Hepatitis B Treatment Market

Increasing Prevalence and Upcoming Novel Therapeutic Approaches: What is Shaping the Hepatitis D Market Outlook?

Get in touch with our Business Executive for Competitive Intelligence Services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences providing end-to-end comprehensive solutions to improve their performance.

Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Tags: , , , , , , , , ,

See Campaign: https://www.delveinsight.com/Contact Information:Kritika Rehani

info@delveinsight.com

+1(919)321-6187Tags:IPS, Reportedtimes, PR-Wirein, Menafn, iCN Internal Distribution, Extended Distribution, Research Newswire, English

More Los Angeles News

Access More

Sign up for Los Angeles News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!